Published in Mol Microbiol on May 01, 1996
Tularemia. Clin Microbiol Rev (2002) 8.51
Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02
A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol (2004) 4.67
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest (1997) 4.62
Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol (2006) 2.68
Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect Immun (2001) 1.91
Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun (2006) 1.73
Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin Diagn Lab Immunol (2000) 1.67
Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. Proc Natl Acad Sci U S A (2007) 1.64
The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci (2007) 1.64
Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev (2009) 1.59
Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun (2008) 1.56
Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol (2010) 1.53
Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun (2006) 1.53
Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect Immun (2000) 1.42
The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun (2006) 1.42
Immunity to Francisella. Front Microbiol (2011) 1.37
Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol (2008) 1.36
Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun (2006) 1.27
Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection. PLoS Pathog (2008) 1.25
Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect Immun (2010) 1.23
Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Microb Pathog (2007) 1.22
A site-specific recombinase is required for competitive root colonization by Pseudomonas fluorescens WCS365. Proc Natl Acad Sci U S A (1998) 1.20
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS One (2010) 1.16
Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge. Vaccine (2009) 1.03
Leptospira interrogans catalase is required for resistance to H2O2 and for virulence. Infect Immun (2012) 0.97
Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. PLoS Pathog (2010) 0.97
Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS. PLoS Pathog (2012) 0.96
Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide o-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy. Front Microbiol (2010) 0.87
Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells. Clin Vaccine Immunol (2014) 0.87
Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C. PLoS One (2011) 0.86
Identification of a live attenuated vaccine candidate for tularemia prophylaxis. PLoS One (2013) 0.85
From the Outside-In: The Francisella tularensis Envelope and Virulence. Front Cell Infect Microbiol (2015) 0.85
T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs. Infect Immun (2014) 0.83
The atypical lipopolysaccharide of Francisella. Carbohydr Res (2013) 0.81
Resistance to peroxynitrite in Neisseria gonorrhoeae. Microbiology (2009) 0.80
Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors. PLoS One (2015) 0.76
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Growth of Francisella spp. in rodent macrophages. Infect Immun (1991) 3.81
MglA and MglB are required for the intramacrophage growth of Francisella novicida. Mol Microbiol (1998) 3.29
Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J Biol Chem (1996) 2.08
Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science (1985) 1.85
Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J Immunol (1992) 1.70
Partial amino acid sequence and molecular cloning of the encoding gene for the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1985) 1.63
Transformation and allelic replacement in Francisella spp. J Gen Microbiol (1991) 1.56
Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci U S A (1987) 1.40
Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol Lett (2000) 1.35
Molecular characterization of Chlamydia trachomatis and Chlamydia psittaci plasmids. Infect Immun (1986) 1.35
Plasmid rearrangements in the photosynthetic bacterium Rhodopseudomonas sphaeroides. J Bacteriol (1984) 1.34
A novel 3-deoxy-D-manno-octulosonic acid transferase from Chlamydia trachomatis required for expression of the genus-specific epitope. J Biol Chem (1992) 1.26
Expression of the transposable lac operon Tn951 in Rhodopseudomonas sphaeroides. J Bacteriol (1982) 1.23
Mycobacterium tuberculosis efpA encodes an efflux protein of the QacA transporter family. Clin Diagn Lab Immunol (1997) 1.19
Isolation of ribosomal subunits containing intact rRNA from human placenta: estimation of functional activity of 80S ribosomes. Anal Biochem (1991) 1.18
Electroporation of Francisella tularensis. Methods Mol Biol (1995) 1.08
Serum-sensitive mutation of Francisella novicida: association with an ABC transporter gene. Microbiology (1994) 1.07
An erythromycin resistance cassette and mini-transposon for constructing transcriptional fusions to cat. Gene (1999) 1.05
The respiratory burst-inhibiting acid phosphatase AcpA is not essential for the intramacrophage growth or virulence of Francisella novicida. FEMS Microbiol Lett (1999) 1.04
Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature. J Bacteriol (1997) 1.02
Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression. FEMS Microbiol Lett (1994) 0.99
Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific chlamydial epitope. Infect Immun (1987) 0.92
Lipoarabinomannan from Mycobacterium tuberculosis modulates the generation of reactive nitrogen intermediates by gamma interferon-activated macrophages. FEMS Immunol Med Microbiol (1994) 0.89
Molecular cloning of the recA gene and construction of a recA strain of Francisella novicida. Infect Immun (1992) 0.88
Assessment of the serodiagnostic potential of nine novel proteins from Mycobacterium tuberculosis. FEMS Microbiol Lett (2001) 0.87
Suppression of Francisella tularensis growth in the rat by co-infection with F. novicida. FEMS Microbiol Lett (1997) 0.86
Molecular cloning of a gene encoding a Chlamydia psittaci 57-kDa protein that shares antigenic determinants with ca. 60-kDa proteins present in many gram-negative bacteria. FEMS Microbiol Lett (1989) 0.85
Broad-host-range plasmid vector for the in vitro construction of transcriptional/translational lac fusions. Gene (1985) 0.84
The lactose carrier of Escherichia coli functionally incorporated in Rhodopseudomonas sphaeroides obeys the regulatory conditions of the phototrophic bacterium. FEBS Lett (1983) 0.83
New vectors for the in vitro generation of alkaline phosphatase fusions to proteins encoded by G+C-rich DNA. Gene (1995) 0.83
Arg276 of GseA, a Chlamydia trachomatis Kdo transferase, is required for the synthesis of the chlamydial genus-specific epitope in Escherichia coli. FEMS Microbiol Lett (1992) 0.77
Identification of novel immunogenic Mycobacterium tuberculosis peptides that stimulate mononuclear cells from immune donors. FEMS Microbiol Lett (1999) 0.75
Heat-labile proteases in molecular biology applications. FEMS Microbiol Lett (2001) 0.75